Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis
Top Cited Papers
Open Access
- 1 January 2017
- journal article
- review article
- Published by Elsevier in The Lancet HIV
- Vol. 4 (1) , e21-e30
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother‐to‐child transmissionHIV Medicine, 2013
- Highly Active Antiretroviral Therapy and Adverse Birth Outcomes Among HIV-Infected Women in BotswanaThe Journal of Infectious Diseases, 2012
- A New Piece in the Puzzle of Antiretroviral Therapy in Pregnancy and Preterm Delivery RiskClinical Infectious Diseases, 2012
- Premature Delivery in HIV-Infected Women Starting Protease Inhibitor Therapy During Pregnancy: Role of the Ritonavir Boost?Clinical Infectious Diseases, 2012
- Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor-Based HAART During PregnancyThe Journal of Infectious Diseases, 2011
- Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conceptionSexually Transmitted Infections, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV‐1‐infected womenHIV Medicine, 2008
- Treatment with Protease Inhibitors and Coinfection with Hepatitis C Virus Are Independent Predictors of Preterm Delivery in HIV‐Infected Pregnant WomenThe Journal of Infectious Diseases, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003